Abacus Medicine A/S Reports Earnings Results for the First Quarter of 2019; Provides Revenue Guidance for the 2019 Fiscal Year
For the 2019 fiscal year, Abacus Medicine expects revenue growth compared to fiscal year 2018 to be in the range of 20% to 35%, which corresponds to revenues between EUR 400 and EUR 445 million.